| 16 March 2022 | Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
| Lin, S; Kennedy, NA; Saifuddin, A; et al. |
| 26 February 2019 | Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
| Walker, G; Walker, GJ; Harrison, JW; et al. |
| 4 May 2020 | Clinical features and genetic risk of demyelination following anti-TNF treatment
| Lin, S; Green, HD; Hendy, P; et al. |
| 26 June 2020 | Genetic evidence that higher central adiposity causes gastro-oesophageal reflux disease: a Mendelian-randomization study
| Green, HD; Beaumont, RN; Wood, AR; et al. |
| 24 May 2019 | Genome-wide association study of microscopic colitis in the UK Biobank confirms immune-related pathogenesis
| Green, HD; Beaumont, RN; Thomas, A; et al. |
| 16 April 2024 | Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
| Chanchlani, N; Lin, S; Bewshea, C; et al. |
| 27 February 2019 | Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
| Kennedy, NA; Heap, GA; Green, HD; et al. |
| 15 May 2023 | Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn's Disease
| Chanchlani, N; Lin, S; Smith, R; et al. |
